Skip to content

Comparison of the effectiveness of GnRH agonist stop-Antagonist protocol versus GnRH antagonist protocol in IVF candidate patients

Comparison of the effectiveness of GnRH agonist stop-Antagonist protocol versus GnRH antagonist protocol in poor respondent IVF candidate patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20110731007165N10
Enrollment
74
Registered
2020-12-15
Start date
2020-12-10
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: Intervention group: GnRH(0.1 mg/daily) will be injected from mid-luteal phase until mense then in the second day of menstrual cycle recombinant FSH with LH will be injected. When the s

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: The criteria for diagnosing poor ovarian response are two of the following:1- Age 40 or older 2 - History of poor ovarian response (POR) in the previous cycle (oocyte less than 3 in a conventional protocol), 3-Antral follicle count (AFC) less than 5-7 or Anti-Müllerian hormone (AMH) <0.5-1.1. Twice poor ovarian response after maximal ovarian stimulation is sufficient reason to introduce the individual as POR without the need for other criteria.

Exclusion criteria

Exclusion criteria: Polycystic ovarian syndrome Hypothalamic amenorrhea Uterine congenital anomalies and uterine cavity abnormalities (Bicorn uterus, Unicorn uterus, Asherman, Liomyuma, Polyp, etc.) Repeated IVF failure (more than three consecutive failures) Endocrine disorders (diabetes, thyroid disease, antipolipid syndrome, cardiovascular and liver disease),

Design outcomes

Secondary

MeasureTime frame
Embryo quality. Timepoint: Embryo formation. Method of measurement: By the embryologist.;Oocyte count. Timepoint: Puncture Day. Method of measurement: by embryologist.

Primary

MeasureTime frame
Number of mature oocytes. Timepoint: During IVF process. Method of measurement: Embryologist opinion.;Number of mature oocytes at retrieval. Timepoint: During IVF process. Method of measurement: Embryologist opinion.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLadan Kashani

Tehran University of Medical Sciences

kashani_ladan@tums.ac.ir+98 21 8828 1866

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026